Hikma Pharmaceuticals PLC - EIP B Vesting
LONDON, 7 March 2022: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 27 February 2020 under the 2014 Executive Incentive Plan ("EIP") Element B. The vesting process was completed on 4 March 2022.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Said Darwazah |
2 |
Reason for the notification |
|
a) |
Position/status |
Executive Chairman |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 47,169 |
d) |
Aggregated information
-
Volume - Price
- Total |
47,169 £0.00 £0.00 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Siggi Olafsson
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Sigurdur Olafsson |
2 |
Reason for the notification |
|
a) |
Position/status |
Chief Executive Officer |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 32,850
Price(s): £19.57 Volume(s): 20,298 |
d) |
Aggregated information
-
Volume - Price
- Total |
53,148 £19.57 £397,231.86 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Mazen Darwazah
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Mazen Darwazah |
2 |
Reason for the notification |
|
a) |
Position/status |
Executive Vice Chairman |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 32,993 |
d) |
Aggregated information
-
Volume - Price
Total |
32,993 £0.00 £0.00 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Riad Mishlawi
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Riad Mishlawi |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 27,086 |
d) |
Aggregated information
-
Volume - Price
- Total |
27,086 £0.00 £0.00 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Majda Labadi
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Majda Labadi |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 14,211 |
d) |
Aggregated information
-
Volume - Price
- Total |
14,211 £0.00 £0.00 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Bassam Kanaan
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Bassam Kanaan |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 22,610 |
d) |
Aggregated information
-
Volume - Price
- Total |
22,610 £0.00 £0.00 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Khalid Nabilsi
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Khalid Nabilsi |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 22,709 |
d) |
Aggregated information
-
Volume - Price
- Total |
22,709 £0.00 £0.00 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Brian Hoffmann
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Brian Hoffmann |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 8,925
Price(s): £19.57 Volume(s): 5,516 |
d) |
Aggregated information
-
Volume - Price
- Total |
14,441 £19.57 £107,948.12 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Susan Ringdal
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Susan Ringdal |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 6,199
Price(s): £19.57 Volume(s): 5,550 |
d) |
Aggregated information
-
Volume - Price
- Total |
11,749 £19.57 £108,613.50 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Henriette Nielsen
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Henriette Nielsen |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 9,663
Price(s): £19.57 Volume(s): 5,972 |
d) |
Aggregated information
-
Volume - Price
- Total |
15,635 £19.57 £116,872.04 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Shahin Fesharaki
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Shahin Fesharaki |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 4,791
Price(s): £19.57 Volume(s): 2,961 |
d) |
Aggregated information
-
Volume - Price
- Total |
7,752 £19.57 £57,946.77 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Hussein Arkhagha
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Hussein Arkhagha |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from the vesting of conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 11,308 |
d) |
Aggregated information
-
Volume - Price
- Total |
11,308 £0.00 £0.00 |
e) |
Date of the transaction |
4 March 2022 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
7 March 2022